0001824293-24-000144.txt : 20241025 0001824293-24-000144.hdr.sgml : 20241025 20241025171844 ACCESSION NUMBER: 0001824293-24-000144 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241025 DATE AS OF CHANGE: 20241025 EFFECTIVENESS DATE: 20241025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GRI BIO, Inc. CENTRAL INDEX KEY: 0001824293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824369909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-527895 FILM NUMBER: 241397891 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (619) 400-1171 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20200910 D 1 primary_doc.xml X0708 D LIVE 0001824293 GRI BIO, Inc. 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA CALIFORNIA 92037 (619) 400-1171 DELAWARE Vallon Pharmaceuticals, Inc. Corporation true Walter Marc Hertz 2223 AVENIDA DE LA PLAYA, STE. 208 La Jolla CA CALIFORNIA 92037 Executive Officer Director Leanne Kelly 2223 AVENIDA DE LA PLAYA, STE. 208 La Jolla CA CALIFORNIA 92037 Executive Officer David Baker 2223 AVENIDA DE LA PLAYA, STE. 208 La Jolla CA CALIFORNIA 92037 Director Roelof Rongen 2223 AVENIDA DE LA PLAYA, STE. 208 La Jolla CA CALIFORNIA 92037 Director Camilla Simpson 2223 AVENIDA DE LA PLAYA, STE. 208 La Jolla CA CALIFORNIA 92037 Director David Szekeres 2223 AVENIDA DE LA PLAYA, STE. La Jolla CA CALIFORNIA 92037 Director Biotechnology Decline to Disclose 06b false 2024-10-21 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Ave. New York NY NEW YORK 10022 NY NEW YORK false 762236 762236 0 false 3 60979 0 The Company also issued to H.C. Wainwright & Co., LLC or its designees warrants to purchase up to 53,357 shares of common stock that are immediately exercisable with a five-year term from the issuance date and a $1.25 per share exercise price. 0 false GRI BIO, Inc. Leanne Kelly Leanne Kelly Chief Financial Officer 2024-10-25